US HB8177 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on September 4 2020 - 25% progression, died in committee
Action: 2020-09-04 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 4 2020 - 25% progression, died in committee
Action: 2020-09-04 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Allows coverage of prescription vitamin and mineral products under the Medicare prescription drug benefit if the products are administered orally and are used to treat iron deficiency anemia in individuals who have chronic kidney disease.
Title
RAISE Act Renal Anemia Innovation Support and Expansion Act
Sponsors
| Rep. Tom O'Halleran [D-AZ] | Rep. Larry Bucshon [R-IN] | Rep. G. Butterfield [D-NC] | Sen. Markwayne Mullin [R-OK] |
History
| Date | Chamber | Action |
|---|---|---|
| 2020-09-04 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2020-09-04 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2020-09-04 | House | Introduced in House |
Subjects
Blood and blood diseases
Digestive and metabolic diseases
Health
Health care coverage and access
Medicare
Prescription drugs
Digestive and metabolic diseases
Health
Health care coverage and access
Medicare
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/8177/all-info |
| Text | https://www.congress.gov/116/bills/hr8177/BILLS-116hr8177ih.pdf |
